The Mitsubishi Tanabe Pharma Group engages Healthcare Professionals (HCPs) and Healthcare Organisations (HCOs) across Europe.
In accordance with the EFPIA Code of Transfers of Value from Pharmaceutical Companies 2019, details of Transfers of Value made to HCPs and HCOs in Europe by the Mitsubishi Tanabe Pharma Group can be found below.
The methodology applied in preparing and collating this data is available here in English*, French* and German*. test
If you are a Healthcare Professional and have any questions regarding the figures disclosed, please contact:
Finance@mt-pharma-eu.com.
2023 Transfers of Value
| Austria | |
|---|---|
| Research & Development | EUR 48,999.93 |
| Non-Research & Development | EUR 81,371.39 |
| Full details here | |
| Belgium | |
|---|---|
| Research & Development | EUR 33,849.50 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Bulgaria | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Croatia | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Cyprus | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Czech Republic | |
|---|---|
| Research & Development | CZK 164,499.80 |
| Non-Research & Development | CZK 0.00 |
| Full details here | |
| Denmark | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Estonia | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Finland | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| France | |
|---|---|
| Research & Development | EUR 125.216.51 |
| Non-Research & Development | EUR 1,000.00 |
| Full details here | |
| Germany | |
|---|---|
| Research & Development | EUR 496,871.85 |
| Non-Research & Development | EUR 59.972.65 |
| Full details here | |
| Greece | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Hungary | |
|---|---|
| Research & Development | HUF 339,935.00 |
| Non-Research & Development | HUF 0.00 |
| Full details here | |
| Ireland | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Italy | |
|---|---|
| Research & Development | EUR 505,341.33 |
| Non-Research & Development | EUR 16,000.00 |
| Full details here | |
| Latvia | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Lithuania | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Malta | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| The Netherlands | |
|---|---|
| Research & Development | EUR 168,121.33 |
| Non-Research & Development | EUR 4,135.00 |
| Full details here | |
| Norway | |
|---|---|
| Research & Development | NOK 430,832.18 |
| Non-Research & Development | NOK 0.00 |
| Full details here | |
| Poland | |
|---|---|
| Research & Development | PLN 381,828.97 |
| Non-Research & Development | PLN 0.00 |
| Full details here | |
| Portugal | |
|---|---|
| Research & Development | EUR 27,201.42 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Romania | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Russia | |
|---|---|
| Research & Development | EUR 40,041.49 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Serbia | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Slovakia | |
|---|---|
| Research & Development | EUR 2,240.88 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Slovenia | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Spain | |
|---|---|
| Research & Development | EUR 167,675.45 |
| Non-Research & Development | EUR 555.00 |
| Full details here | |
| Sweden | |
|---|---|
| Research & Development | SEK 183,237.96 |
| Non-Research & Development | SEK 0.00 |
| Full details here | |
| Switzerland | |
|---|---|
| Research & Development | CHF 139,449.63 |
| Non-Research & Development | CHF 73,322.80 |
| Full details here | |
| Turkey | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 51,106.91 |
| Full details here | |
| Ukraine | |
|---|---|
| Research & Development | EUR 89,090.94 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| United Kingdom | |
|---|---|
| Research & Development | GBP 716,419.24 |
| Non-Research & Development | GBP 122,270.74 |
| Full details here or here (ABPI Website) | |
* The Mitsubishi Tanabe Pharma Group has established legal entities in the United Kingdom, Germany and Switzerland and therefore disclosure is made according to local requirements for these countries
Terms and Privacy
Contact Us
Mitsubishi TANABE Pharma Europe Ltd
Dashwood House
69 Old Broad Street
London
EC2M 1QS
United Kingdom